Respiratory Distress Syndrome in Premature Infants Clinical Trial
Official title:
Stress Assessment in Preterm Infants With Respiratory Distress Syndrome Treated or Not With an Analgesic Drug During the Traditional or the Less Invasive Method of Surfactant Therapy.
This study will compare stress, changes in oxygenation and oxidative damage in preterm infants with respiratory distress syndrome (RDS) randomized to receive or not remifentanil as an analgesic drug during the administration of porcine surfactant (poractant alfa, Curosurf®) through the traditional (INSURE) or the less invasive (LISA) method.
Status | Not yet recruiting |
Enrollment | 80 |
Est. completion date | October 31, 2022 |
Est. primary completion date | October 31, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 168 Days to 223 Days |
Eligibility |
Inclusion Criteria: - gestational age at birth between 168 and 223 days, - respiratory distress syndrome (diagnosed on the basis of clinical and/or radiological grounds) with a fraction of inspired oxygen =0.30 (for infants born =26 weeks' gestational age) or =0.40 (for infants born >26 weeks' gestational age) to achieve a peripheral oxygen saturation of 90-94% within 24 hours of life and good respiratory drive, - written informed consent. Exclusion Criteria: - major malformations, - late admission (after 24 hours of life), - intubation in the delivery room, - severe birth asphyxia, - prolonged rupture of membranes, - air leaks, - no informed consent. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Virgilio Paolo Carnielli | Fondazione Cassa di Risparmio di Verona Vicenza Belluno e Ancona, Istituto di Ricerca Pediatrica Città della Speranza |
Badiee Z, Vakiliamini M, Mohammadizadeh M. Remifentanil for endotracheal intubation in premature infants: A randomized controlled trial. J Res Pharm Pract. 2013 Apr;2(2):75-82. doi: 10.4103/2279-042X.117387. — View Citation
Guinsburg R, Kopelman BI, Anand KJ, de Almeida MF, Peres Cde A, Miyoshi MH. Physiological, hormonal, and behavioral responses to a single fentanyl dose in intubated and ventilated preterm neonates. J Pediatr. 1998 Jun;132(6):954-9. — View Citation
Guinsburg R, Kopelman BI, de Almeida MF, Miyoshi MH. [Pain in intubated and ventilated preterm neonate: multidimensional assessment and response to fentanyl analgesia]. J Pediatr (Rio J). 1994 Mar-Apr;70(2):82-90. Portuguese. — View Citation
Lago P, Benini F, Agosto C, Zacchello F. Randomised controlled trial of low dose fentanyl infusion in preterm infants with hyaline membrane disease. Arch Dis Child Fetal Neonatal Ed. 1998 Nov;79(3):F194-7. — View Citation
Okamura H, Kinoshita M, Saitsu H, Kanda H, Iwata S, Maeno Y, Matsuishi T, Iwata O. Noninvasive surrogate markers for plasma cortisol in newborn infants: utility of urine and saliva samples and caution for venipuncture blood samples. J Clin Endocrinol Metab. 2014 Oct;99(10):E2020-4. doi: 10.1210/jc.2014-2009. Epub 2014 Jul 31. — View Citation
Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, Saugstad OD, Simeoni U, Speer CP, Vento M, Visser GH, Halliday HL. European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2016 Update. Neonatology. 2017;111(2):107-125. doi: 10.1159/000448985. Epub 2016 Sep 21. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cortisol concentrations | Cortisol concentrations will be assessed in saliva, as salivary cortisol levels have been shown to be useful surrogate markers for plasma cortisol levels in neonates. Saliva samples will be collected using an absorbent swab stick, centrifuged at 4000 rpm for 10 minutes and kept at -80°C until assayed (minimum sample volume 25 µl). Enzyme immunoassay (ELISA kit) will be used. Basal samples will be obtained at the hospital admission and right before surfactant. | At 1, 3, 6 12, 24 hours after surfactant administration and then daily in the first week at the same time of the day (to avoid circadian variations). | |
Secondary | Galvanic Skin Responses | An instrumental stress-test device measuring galvanic skin conductance will be used (Pain Monitor, Med-Storm, Norway): three electrodes will be attached to the infant's foot (sole and sides of the ankle); skin conductance is measured in micro Siemens (µS). | At 1, 3, 6 12, 24 hours after surfactant administration and then daily in the first week at the same time of the day (to avoid circadian variations). | |
Secondary | Heart rate | Cardiac monitoring will assess heart rate. Traces will be saved onto a computer with a sampling frequency of 1 Hertz. Average heart rate, periods of tachycardia (>160 bpm for =5 seconds) and bradycardia (<100 bpm for =5 seconds) will be recorded. These parameters may be correlated with stress and hemodynamic instability during the procedures. | 6 hours before and after surfactant therapy will be analyzed. | |
Secondary | Brain oxygenation | Brain oxygenation will be assessed by near-infrared spectroscopy (NIRS). | From the hospital admission to day 7 of the hospital stay. | |
Secondary | Oxygen saturation (SpO2) | High precision oxygenation assessment will be attained by high frequency (1 Hz) sampling of SpO2 data from the cardio monitor to a computer, possibly by using multiple pulse oximeters in the same patient. | From the hospital admission to day 7 of the hospital stay. | |
Secondary | Markers of oxidative stress | 8-isoprostane and nitrites/nitrates will be dosed on urine samples. | At the hospital admission and at 6 and 12 hours after surfactant therapy. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01651637 -
First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome
|
Phase 1 | |
Terminated |
NCT02939742 -
Does a Rescue Course of Betamethasone in Pregnant Women With PPROM Decrease Neonatal Morbidity?
|
Phase 2/Phase 3 | |
Completed |
NCT02770976 -
Respiratory Pattern During Neurally Adjusted Ventilator Assist (NAVA) in Preterm Infants
|
N/A | |
Completed |
NCT02661256 -
Effect of Nasal Continuous Positive Airway Pressure on The Pharyngeal Swallow in Neonates
|
N/A | |
Active, not recruiting |
NCT02445040 -
Safety and Efficacy Study of the Draeger Babylog VN500 Device in HFOV Mode in VLBW Neonates
|
N/A | |
Completed |
NCT01962818 -
High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths: Effects on Lung Volume Monitored by Electric Tomography Impedance.
|
N/A | |
Completed |
NCT02210026 -
Seattle-PAP Bubble Nasal CPAP and Work of Breathing
|
Phase 1 | |
Not yet recruiting |
NCT02200900 -
Study of Respiratory Physiology During High Flow Nasal Cannula Treatment in Preterm Neonates.
|
N/A | |
Completed |
NCT02396693 -
Successful Extubation and Noninvasive Ventilation in Preterm ≤ 1500g Terms
|
N/A | |
Completed |
NCT01220687 -
Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation
|
N/A |